EYPT Jun 2024 25.000 call
| Previous Close | 1.4200 |
| Open | 1.4200 |
| Bid | 0.0000 |
| Ask | 0.2500 |
| Strike | 25.00 |
| Expire Date | 2024-06-21 |
| Day's Range | 1.4200 - 1.4200 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1k |
GlobeNewswireEyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an
- GlobeNewswire
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
WATERTOWN, Mass., June 05, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint Pharmaceuticals will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 3:20 p.m. ET. A live webcast and subsequent archived
GuruFocus.comInsider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)
On June 3, 2024, David Guyer, a Director at EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), executed a sale of 11,625 shares of the company.
